LURBINECTEDIN for Small cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where LURBINECTEDIN was used for Small cell carcinoma.
Most Reported Side Effects for LURBINECTEDIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 129 | 13.4% | 129 | 11 |
| Disease progression | 98 | 10.1% | 28 | 14 |
| Off label use | 69 | 7.1% | 6 | 10 |
| Neutropenia | 59 | 6.1% | 12 | 28 |
| Nausea | 58 | 6.0% | 5 | 15 |
| Thrombocytopenia | 48 | 5.0% | 9 | 22 |
| Fatigue | 43 | 4.5% | 3 | 5 |
| Febrile neutropenia | 39 | 4.0% | 9 | 29 |
| Vomiting | 37 | 3.8% | 5 | 14 |
| Asthenia | 36 | 3.7% | 1 | 13 |
| Anaemia | 34 | 3.5% | 5 | 16 |
| Injection site reaction | 32 | 3.3% | 0 | 0 |
| Acute kidney injury | 28 | 2.9% | 7 | 24 |
| Pneumonia | 27 | 2.8% | 11 | 19 |
| Diarrhoea | 25 | 2.6% | 4 | 12 |
Other Indications for LURBINECTEDIN
Small cell lung cancer (351)
Product used for unknown indication (250)
Small cell lung cancer metastatic (106)
Small cell lung cancer extensive stage (56)
Lung neoplasm malignant (41)
Bladder cancer (11)
Bronchial carcinoma (10)
Neoplasm malignant (8)
Small cell lung cancer recurrent (7)
Lung carcinoma cell type unspecified stage 0 (6)
Other Drugs Used for Small cell carcinoma
ETOPOSIDE (134)
CARBOPLATIN (97)
CISPLATIN (74)
ATEZOLIZUMAB (64)
DOXORUBICIN (28)
CYCLOPHOSPHAMIDE (23)
NIVOLUMAB (23)
IRINOTECAN (14)
IPILIMUMAB (13)
PACLITAXEL (13)